Add to Favorites Newsroom RSS Share
Seattle, WA USA

Our News on Newswise

YesCampaignBanner_MakennaSchwab.jpg

Seattle Children’s Receives $60 Million Legacy Gift

Seattle Children’s today announced it has received the second largest single charitable gift in its 111-year history as the residual beneficiary of the estate of Bruce Leven. The landmark bequest is expected to exceed $60 million.
13-Feb-2018 10:00 AM EST Add to Favorites

TSC_Luke_lead_web.jpg

A New Approach to Caring for Kids with Tuberous Sclerosis Complex

Eight years ago, Dr. Jeff Avansino, a surgeon at Seattle Children’s, and his wife, Dr. Amy Criniti, welcomed their third child – a boy named Luke.
9-Feb-2018 10:05 AM EST Add to Favorites

Immunotherapy, Gene Editing Advances Extend to Type 1 Diabetes

Advances in engineering T cells to treat cancer are paving the way for new immunotherapies targeted at autoimmune diseases, including type 1 diabetes. Now, researchers are also investigating therapies that reprogram T cells to “turn down” an...
13-Dec-2017 12:05 PM EST Add to Favorites

Kean_Leslie_ep_636167.jpg

Immunotherapy Drug for Rheumatoid Arthritis Nearly Eliminates Severe Acute Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplant

Results from a phase 2 clinical trial, presented by Seattle Children’s Research Institute at the 59th American Society of Hematology (ASH) Annual Meeting, show that the drug Abatacept (Orencia) nearly eliminated life-threatening severe acute...
7-Dec-2017 2:00 PM EST Add to Favorites

Richard_James_001.JPG

In Scientific First, Seattle Children's Researchers Engineer B Cells to Treat Disease

Scientists at Seattle Children’s Research Institute have unlocked the ability to engineer B cells, uncovering a potential new cell therapy that could someday prevent and cure disease.
5-Dec-2017 4:05 PM EST Add to Favorites

Erin_Facebook_adj.jpg

Seattle Children's Opens First CAR T-Cell Immunotherapy Trial in the U.S. for Children and Young Adults With Leukemia that Targets CD22 and CD19 Proteins Simultaneously

Seattle Children’s has opened the first chimeric antigen receptor (CAR) T-cell immunotherapy trial in the U.S. for children and young adults with relapsed or refractory CD19- and CD22-positive acute lymphoblastic leukemia (ALL) that will...
16-Nov-2017 9:00 AM EST Add to Favorites

Yes Campaign Banner_Makenna Schwab.jpg

Seattle Children’s Launches $1 Billion Fundraising Campaign to Transform Children’s Health

Seattle Children’s today launched a $1 billion initiative, It Starts With Yes: The Campaign for Seattle Children’s, with a bold vision: to transform children’s health. It Starts With Yes is the largest campaign in Seattle Children’s 110-year...
15-Nov-2017 10:05 AM EST Add to Favorites

ONE_TEAM_NJFL.jpg

Researchers Put Youth Sports Safety and Concussion Awareness Ahead of the Game With Novel Program

Seattle Children’s researchers will launch an innovative program in early 2018 aimed at shifting the culture of safety in youth sports and building concussion awareness during competitive play with the help of pre-game safety huddles.
8-Nov-2017 10:20 AM EST Add to Favorites


see all news

Our Experts on Newswise

Hawkins_Doug_042945_2016.PNG

16-Feb-2018 10:00 AM EST

Experts at Seattle Children's Hospital have put together a Healthy Child Checklist to ensure that children "“ and parents "“ are prepared for the first day of school.
24-Jul-2009 1:00 PM EDT

see all experts

Our YouTube Videos





Chat now!